These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9552198)

  • 21. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.
    Simon J; Nachtigall L; Gut R; Lang E; Archer DF; Utian W
    Obstet Gynecol; 2008 Nov; 112(5):1053-60. PubMed ID: 18978105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption of vaginal estrogen cream during sexual intercourse: a prospective, randomized, controlled trial.
    Hurst BS; Jones AI; Elliot M; Marshburn PB; Matthews ML
    J Reprod Med; 2008 Jan; 53(1):29-32. PubMed ID: 18251358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
    Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen therapy in older patients with recurrent urinary tract infections: a review.
    Rozenberg S; Pastijn A; Gevers R; Murillo D
    Int J Fertil Womens Med; 2004; 49(2):71-4. PubMed ID: 15188831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of topical estrogens to labial fusion and vaginal introital integrity.
    Schober J; Dulabon L; Martin-Alguacil N; Kow LM; Pfaff D
    J Pediatr Adolesc Gynecol; 2006 Oct; 19(5):337-9. PubMed ID: 17060017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is endometrial monitoring required with the use of long-term unopposed vaginal estrogen?
    MacLennan AH; Sturdee DW
    Climacteric; 2006 Oct; 9(5):321-2. PubMed ID: 17000579
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaginal oestrogen therapy after breast cancer: is it safe?
    Ponzone R; Biglia N; Jacomuzzi ME; Maggiorotto F; Mariani L; Sismondi P
    Eur J Cancer; 2005 Nov; 41(17):2673-81. PubMed ID: 16239103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjugated estrogens (Premarin) vaginal cream.
    Med Lett Drugs Ther; 2009 Feb; 51(1306):14-5. PubMed ID: 19229162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative trial of quinestradol and ethinyl oestradiol.
    Beaton D
    Br J Clin Pract; 1967 May; 21(5):241-3. PubMed ID: 6046407
    [No Abstract]   [Full Text] [Related]  

  • 30. By the way, doctor. My doctor prescribed a low-dose vaginal estrogen cream, applied twice a week, for atrophic vaginitis. I've heard this dose is so low that it carries no health risk. Do you agree?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Nov; 15(3):7. PubMed ID: 18225330
    [No Abstract]   [Full Text] [Related]  

  • 31. Managing urogenital atrophy.
    Palacios S
    Maturitas; 2009 Aug; 63(4):315-8. PubMed ID: 19493638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimentation with a new product: FH 123 A].
    Cismigiu F; Gomer M; Heraud M
    Rev Fr Gynecol Obstet; 1973 Oct; 68(10):601-5. PubMed ID: 17474219
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravaginal oestrogen and progestin administration: advantages and disadvantages.
    Cicinelli E
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):391-405. PubMed ID: 17981510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATROPHIC AND SENILE VAGINO-PERINEAL DISORDERS: NEW TREATMENT WITH AN ESTROGEN-PROGESTERONE VAGINAL CREAM.
    KARNAKY KJ
    J Am Geriatr Soc; 1965 Sep; 13():820-7. PubMed ID: 14341030
    [No Abstract]   [Full Text] [Related]  

  • 35. Possible interaction between ethanol and vaginally administered metronidazole.
    Plosker GL
    Clin Pharm; 1987 Mar; 6(3):189, 192-3. PubMed ID: 3665375
    [No Abstract]   [Full Text] [Related]  

  • 36. Report of the American Medical Association Council on Scientific Affairs.
    J Okla State Med Assoc; 1983 Jan; 76(1):8-12. PubMed ID: 6834171
    [No Abstract]   [Full Text] [Related]  

  • 37. Differences in vaginal dryness according to hormone therapy schedule using pH test strip in two groups of postmenopausal women.
    Carranza-Lira S; MacGregor-Gooch AL
    Int J Fertil Womens Med; 2004; 49(2):88-90. PubMed ID: 15188835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term vaginal antibody delivery: delivery systems and biodistribution.
    Saltzman WM; Sherwood JK; Adams DR; Castle P; Haller P
    Biotechnol Bioeng; 2000 Feb; 67(3):253-64. PubMed ID: 10620255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel chromene-derived selective estrogen receptor modulators useful for alleviating hot flushes and vaginal dryness.
    Jain N; Kanojia RM; Xu J; Jian-Zhong G; Pacia E; Lai MT; Du F; Musto A; Allan G; Hahn D; Lundeen S; Sui Z
    J Med Chem; 2006 Jun; 49(11):3056-9. PubMed ID: 16722623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.